The University of Derby Is Leading The £1.2m Study That Involves About 100 People Who Have lived With The Condition For More Than Two Years .
Dr Mark Faghy Said The Nine-Month Project Would Test REMDESIVIR, Which Had Been Used To Treat Acute Covid .
SE PUEDE YA AFIRMAR QUE TARLATAMAB ( IMDELLTRA BY AMGEN ) SUPERA AMPLIAMENTE AL LURBINECTEDIN ( ZEPZELCA BY PHARMAMAR ) TANTO EN PRIMERA LÍNEA DE MANTENIMIENTO ... COMO EN SEGUNDA LINEA PARA EL TRATAMIENTO ESTÁNDAR DE SMALL CELL LUNG CANCER EXTENSIVE-STAGE .
The University of Derby Is Leading The £1.2m Study That Involves About 100 People Who Have lived With The Condition For More Than Two Years .
Dr Mark Faghy Said The Nine-Month Project Would Test REMDESIVIR, Which Had Been Used To Treat Acute Covid .